Ambu A/S Approves Distribution for the Year 2015; Announces Board Changes
December 10, 2015 at 10:41 pm IST
Share
Ambu A/S held its annual general meeting on 10 December 2015. The shareholders approved the distribution of the profit for the year 2015 and dividend of DKK 0.95 per share will consequently be distributed, corresponding to 30% of the net profit.
The shareholders elected Henrik Ehlers Wulff and Oliver Johansen as new members of the Board. Jesper Funding Andersen and John Stær are not up for re-election. Henrik Ehlers Wulff is Executive Vice President, Novo Nordisk Product Supply. Henrik has been with Novo Nordisk since 1998 where he has held a number of management positions. In 2015, he was appointed Executive Vice President and became a member of the Executive Management. Henrik Wulff has served as a member of the Board of Directors of Novo Nordisk PharmaTech A/S several times since 2009, for the past two years as chairman. He is also a member of the Board of Directors of NNE Pharmaplan A/S. Oliver Johansen Senior Vice President Global Research & Development, Chronic Care in Coloplast. Oliver Johansen has been with Coloplast since 2002, initially joining as Logistics Manager. In 2007, he was appointed VP, Supply Chain Management and International Manufacturing, Global Operations. Oliver Johansen is a member of the Board of Directors of Acarix.
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows:
- single-use endoscopes (56.3%);
- emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers;
- monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid.
At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico.
Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).